Latest news
CRISPR Therapeutics (CRSP) Earnings Drew Fresh Interest, Is The Stock Below Fair Value? - simplywall.stsimplywall.st · Sat, 08 Aug 2026 06:26:15 GMTCRISPR Therapeutics (NASDAQ:CRSP) Rating Increased to Hold at Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 05:48:57 GMTWill Phase III lonvo-z Data and Resumed ATTR Program Change Intellia Therapeutics' (NTLA) Narrative - simplywall.stsimplywall.st · Fri, 07 Aug 2026 13:40:06 GMTGoldman Sachs Keeps Their Hold Rating on Crispr Therapeutics AG (CRSP) - The Globe and MailThe Globe and Mail · Fri, 07 Aug 2026 12:02:00 GMTCalifornia State Teachers Retirement System Increases Stock Position in CRISPR Therapeutics AG $CRSP - MarketBeatMarketBeat · Fri, 07 Aug 2026 08:22:56 GMTBrave Asset Management Inc. Cuts Stake in CRISPR Therapeutics AG $CRSP - MarketBeatMarketBeat · Fri, 07 Aug 2026 08:20:29 GMTDimensional Fund Advisors LP Sells 412,889 Shares of CRISPR Therapeutics AG $CRSP - MarketBeatMarketBeat · Fri, 07 Aug 2026 08:20:28 GMTRBC Capital Keeps Their Hold Rating on Crispr Therapeutics AG (CRSP) - The Globe and MailThe Globe and Mail · Fri, 07 Aug 2026 01:54:00 GMT